United States Federal Circuit
INVITROGEN CORP. v. BIOCREST MFG., L.P., 02-1207, 02-1260
Because the district court incorrectly construed the claims of a patent involving DNA technology, its summary judgment finding that defendant did not infringe plaintiff's patent is reversed.
Appellate Information
- Decided 05/07/2003
- Published 05/07/2003
Judges
- RADER, Circuit Judge., Before RADER, BRYSON, and DYK, Circuit Judges.
Court
- United States Federal Circuit
Counsel
- For Appellant:
- Francis M. Wilkstrom,Parsons Behle & Latimer, of Salt Lake City, UT, argued for plaintiff-appellant. With him on the brief were C. Kevin Speirs and Kristine Edde Johnson. Of counsel on the brief was Alan W. Hammond, Invitrogen Corporation, of Carlsbad, CA.
- For Appellees:
- Marc R. Labgold, Ph.D., Patton Boggs LLP, of McLean, VA, argued for defendants-cross appellants. With him on the brief were Kevin M. Bell and Laura A. Donnelly. Of counsel on the brief was Richard J. Oparil, Patton Boggs LLP, of Washington, DC.